AMAL on Nasdaq
Amalgamated Financial Corp.
$47.16 up 0.64 (1.36%)Price as of Oct 15, 2026 at 17:33 UTC
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement in the latest annual report, as filed.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Loans | $240.6M | $215.4M | $191.3M |
| Securities | $176.3M | $177.2M | $161.0M |
| Interest-bearing deposits in banks | $5.3M | $8.7M | $5.8M |
| Total interest and dividend income | $422.2M | $401.3M | $358.1M |
| Deposits | $121.6M | $113.5M | $81.1M |
| Borrowed funds | $2.9M | $5.4M | $15.6M |
| Total interest expense | $124.4M | $118.9M | $96.8M |
| NET INTEREST INCOME | $297.8M | $282.4M | $261.3M |
| Provision for credit losses | $16.3M | $10.3M | $14.7M |
| Net interest income after provision for credit losses | $281.5M | $272.1M | $246.6M |
| Trust Department fees | $16.2M | $15.2M | $15.2M |
| Service charges on deposit accounts | $17.5M | $32.2M | $11.0M |
| Bank-owned life insurance income | $3.1M | $2.5M | $2.9M |
| Losses on sale of securities and other assets, net | -$3.4M | -$9.7M | -$7.4M |
| Gain (loss) on sale of loans and changes in fair value on loans held-for-sale, net | -$2.7M | -$8.2M | $32.0K |
| Equity method investments income (loss) | -$1.7M | -$831.0K | $4.9M |
| Other income | $2.0M | $2.1M | $2.7M |
| Total non-interest income | $30.9M | $33.2M | $29.3M |
| Compensation and employee benefits | $98.6M | $93.8M | $85.8M |
| Occupancy and depreciation | $13.4M | $13.1M | $13.6M |
| Professional fees | $14.3M | $10.0M | $9.6M |
| Technology | $24.1M | $19.8M | $17.7M |
| Office maintenance and depreciation | $2.1M | $2.5M | $2.8M |
| Amortization of intangible assets | $574.0K | $730.2K | $887.7K |
| Advertising and promotion | $2.4M | $3.7M | $4.2M |
| Federal deposit insurance premiums | $3.8M | $3.7M | $4.0M |
| Other expense | $13.1M | $12.5M | $12.6M |
| Total non-interest expense | $172.2M | $159.8M | $151.2M |
| Income before income taxes | $140.2M | $145.6M | $124.7M |
| Income tax expense | $35.7M | $39.2M | $36.8M |
| Net income | $104.4M | $106.4M | $88.0M |
| Earnings per common share - basic (in dollars per share) | $3.44 | $3.48 | $2.88 |
| Earnings per common share - diluted (in dollars per share) | $3.41 | $3.44 | $2.86 |
Every line of the balance sheet in the latest annual report, as filed.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and due from banks | $4.5M | $4.0M | |
| Interest-bearing deposits in banks | $286.7M | $56.7M | |
| Total cash and cash equivalents | $291.2M | $60.7M | |
| Available for sale, at fair value | $1.8B | $1.6B | |
| Held-to-maturity, at amortized cost | $1.6B | $1.6B | |
| Loans held for sale | $2.8M | $37.6M | |
| Loans receivable, net of deferred loan origination fees and costs | $5.0B | $4.7B | |
| Allowance for credit losses | -$57.6M | -$60.1M | -$65.7M |
| Loans receivable, net | $4.9B | $4.6B | |
| Resell agreements | $48.7M | $23.7M | |
| "Federal Home Loan Bank of New York (""FHLBNY"") stock, at cost" | $5.0M | $15.7M | |
| Accrued interest receivable | $65.1M | $61.2M | |
| Premises and equipment, net | $4.7M | $6.4M | |
| Bank-owned life insurance | $108.9M | $108.0M | |
| Right-of-use lease asset | $9.6M | $14.2M | |
| Deferred tax asset, net | $30.8M | $42.4M | |
| Goodwill | $12.9M | $12.9M | |
| Intangible assets, net | $913.0K | $1.5M | |
| Equity method investments | $8.0M | $8.5M | |
| Other assets | $43.9M | $35.9M | |
| Total assets | $8.9B | $8.3B | |
| Deposits | $7.9B | $7.2B | |
| Borrowings | $69.5M | $314.4M | |
| Operating leases | $12.3M | $19.7M | |
| Other liabilities | $44.3M | $34.5M | |
| Total liabilities | $8.1B | $7.5B | |
| Common stock, par value $0.01 per share (70,000,000 shares authorized; 31,045,377 and 30,809,484 shares issued, respectively, and 29,818,424 and 30,670,982 shares outstanding, respectively) | $312.0K | $308.0K | |
| Additional paid-in capital | $294.1M | $288.7M | |
| Retained earnings | $567.3M | $480.1M | |
| Accumulated other comprehensive loss, net of income taxes | -$32.1M | -$58.6M | |
| Treasury stock, at cost (1,226,953 and 138,502 shares, respectively) | -$35.2M | -$2.8M | |
| Total stockholders' equity | $794.5M | $707.7M | $585.4M |
| Total liabilities and stockholders equity | $8.9B | $8.3B | |
| Held-to-maturity, allowance for credit losses | $744.0K | $704.0K | $721.0K |
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | |
| Common stock, shares authorized (in shares) | 70.0M shares | 70.0M shares | |
| Common stock, shares issued (in shares) | 31.0M shares | 30.8M shares | |
| Common stock, shares outstanding (in shares) | 29.8M shares | 30.7M shares | |
| Treasury stock, cost (in shares) | 1.2M shares | 138.5K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.8
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $104.4M | $106.4M | $88.0M |
| Depreciation and amortization | $6.2M | $4.7M | $5.5M |
| Amortization of intangible assets | $574.0K | $730.2K | $887.7K |
| Deferred income tax expense | $1.7M | $5.2M | $4.2M |
| Provision for credit losses | $16.3M | $10.3M | $14.7M |
| Stock-based compensation expense | $6.9M | $5.5M | $4.7M |
| Net (income) loss from equity method investments | $1.7M | $831.0K | -$4.9M |
| Net loss on sale of securities available for sale and other assets | $3.4M | $9.7M | $7.4M |
| Net (gain) loss on sale of loans and change in fair value on loans held-for-sale | $2.7M | $8.2M | -$32.0K |
| Net gain on death benefits of bank-owned life insurance | -$562.0K | $0 | -$613.0K |
| Net gain on repurchase of subordinated debt | $0 | -$1.1M | -$1.4M |
| Proceeds from sales of loans held for sale | $29.0M | $22.1M | $17.8M |
| Originations of loans held for sale | -$30.1M | -$21.7M | -$14.6M |
| Increase in cash surrender value of bank-owned life insurance | -$2.6M | -$2.5M | -$2.3M |
| Increase in accrued interest receivable | -$4.0M | -$5.7M | -$14.0M |
| Decrease (increase) in other assets | -$856.0K | -$2.4M | $11.7M |
| Increase (decrease) in other liabilities | $778.0K | -$16.2M | $181.0K |
| Net cash provided by operating activities | $135.8M | $124.1M | $117.2M |
| Net increase in loans | -$342.0M | -$360.2M | -$317.2M |
| Proceeds from sales of loans | $73.2M | $36.6M | $0 |
| Purchase of securities available for sale | -$965.0M | -$824.5M | -$116.5M |
| Purchase of securities held-to-maturity | -$158.0M | -$92.2M | -$264.5M |
| Proceeds from sales of securities available for sale | $364.8M | $394.1M | $285.4M |
| Maturities, principal payments and redemptions of securities available for sale | $477.9M | $310.8M | $167.8M |
| Maturities, principal payments and redemptions of securities held-to-maturity | $190.9M | $204.3M | $108.9M |
| Decrease (increase) in resell agreements | -$24.9M | $26.3M | -$24.2M |
| Decrease (increase) in equity method investments | -$6.5M | $1.9M | -$757.0K |
| Decrease (increase) in FHLBNY stock, net | $10.7M | -$11.3M | $25.2M |
| Purchases of premises and equipment, net | -$1.4M | -$1.8M | -$1.5M |
| Proceeds from redemption of bank-owned life insurance | $2.2M | $0 | $2.9M |
| Proceeds from sale of owned assets | $46.0K | $0 | $0 |
| Net cash used in investing activities | -$378.0M | -$315.9M | -$134.4M |
| Net increase in deposits | $768.6M | $168.6M | $417.0M |
| Increase (decrease) in other borrowings, net | -$244.9M | $16.3M | -$345.6M |
| Repurchase of subordinated debt | $0 | -$5.9M | -$6.0M |
| Common stock issued under Equity Program | $1.4M | $789.0K | $804.0K |
| Redemption of AREMCO class B shares | $0 | -$152.0K | $0 |
| Repurchase of common stock | -$32.3M | -$1.1M | -$8.3M |
| Dividends paid on common stock | -$17.2M | -$14.2M | -$12.3M |
| Payments related to repurchase of common stock for equity awards | -$2.8M | -$2.2M | -$1.2M |
| Net cash provided by financing activities | $472.7M | $162.1M | $44.2M |
| Increase (decrease) in cash, cash equivalents, and restricted cash | $230.5M | -$29.8M | $27.0M |
| Interest paid during the year | $124.4M | $128.8M | $85.7M |
| Right-of-use assets obtained in exchange for lease liabilities | $2.9M | $560.0K | $0 |
| Loans transferred from held-for-sale | $2.5M | $0 | $4.7M |
| Loans transferred to held-for-sale | $42.5M | $81.6M | $3.6M |
| Cumulative change due to adoption of ASU No. 2016-13 | $0 | $0 | $17.8M |
Recent filings
- Oct 5, 20264
- Sep 17, 20264 PRIMARY DOCUMENT
- Sep 15, 20264
- Sep 15, 20264
- Sep 15, 2026144
- Sep 14, 2026144/A
- Sep 11, 20264
- Sep 11, 20264
- Sep 11, 2026144
- Sep 11, 20264
- Sep 11, 20264
- Sep 10, 2026144
- Sep 10, 2026144
- Sep 10, 20264
- Sep 10, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2Yahoo FinanceAMAL quote
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11